is There an Alternative to Ultrasound Guided Interscalene Block?

Tunisian Military Hospital

Status: Unknown

Conditions: Shoulder Surgery; Interscalene Block; Regional Anesthesia

Treatments: Drug: morphine; Device: ultrasound; Drug: bupivacaine

Study type: Interventional

Funder types: Other

Identifiers

NCT02397330

TunisianMH1

Details and patient eligibility

About

Interscalene brachial plexus block is the gold standard for perioperative pain management in shoulder surgery. However, this technique would have side effects and potential serious complications. The aim of this study is to compare between the combination of ultrasound guided suprascapular and supraclavicular nerve blocks versus ultrasound guided interscalene brachial plexus block for post operative analgesia after shoulder instability surgery with latarjet procedure.

Enrollment: 60 estimated patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ASA physical status I-III
• 18-75 years of age, inclusive
• shoulder surgery (LATARJET technique)

Exclusion criteria

• contraindications to brachial plexus block (e.g., allergy to local anesthetics, coagulopathy, malignancy or infection in the area)
• existing neurological deficit
• pregnancy
• history of neck surgery or radiotherapy
• severe respiratory disease
• inability to understand the informed consent and demands of the study

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

60 participants in 2 patient groups

group BIS

Active Comparator group

Description:

scheduled for ultrasound guided interscalene blockade with 30 ml of bupivacaine 0.25%

Treatment:

Device: ultrasound

Drug: morphine

Drug: bupivacaine

group BS

Experimental group

Description:

scheduled for selective blockade of the ultrasound guided suprascapular (15 ml bupivacaine 0.25%) and supraclavicular (15 ml bupivacaine 0.25%) nerves blocks

Treatment:

Device: ultrasound

Drug: morphine

Drug: bupivacaine